RecruitingPhase 3NCT06935370A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartSponsor: Boehringer IngelheimAmarillo, TX · Beaumont, TX · +86 more sites
RecruitingPhase 3NCT07761117A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFSponsor: AstraZenecaDallas, TX · DeSoto, TX · El Paso, TX · +117 more sites
RecruitingPhase 3NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesitySponsor: AmgenAmarillo, TX · Austin, TX · Conroe, TX · +118 more sites
RecruitingPhase 3NCT06677060Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinSponsor: AstraZenecaAbilene, TX · Austin, TX · Beaumont, TX · +195 more sites
RecruitingPhase 1NCT07219511A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Sponsor: Vasa TherapeuticsDallas, TX · Tomball, TX · +19 more sites